Akoya to Participate at Three Upcoming Investor Conferences
Get Alerts AKYA Hot Sheet
Join SI Premium – FREE
MARLBOROUGH, Mass., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that it will be participating in three upcoming investor conferences.
- Stephens Annual Investment Conference (Nashville, TN)Fireside Chat on Wednesday, November 16th at 2:00 PM CT
- Canaccord Genuity Annual MedTech, Diagnostics and Digital Health & Services Forum (New York, NY)Multi-omics Panel on Thursday, November 17th at 1:00 PM ET
- Piper-Sandler Annual Healthcare Conference (New York, NY)Fireside Chat on Thursday, December 1st at 11:30 AM ET
Live and archived webcasts of the events will be available on the “Investors” section of the Akoya website at https://investors.akoyabio.com/.
About Akoya BiosciencesAs The Spatial Biology Company®, Akoya Biosciences’ mission is to bring context to the world of biology and human health through the power of spatial phenotyping. The company offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and response to therapy. Akoya offers a full continuum of spatial phenotyping solutions to serve the diverse needs of researchers across discovery, translational and clinical research via its key platforms: PhenoCycler™, PhenoImager™ Fusion and PhenoImager HT. To learn more about Akoya, visit www.akoyabio.com.
Investor Contact:Priyam ShahSr. Director, Investor RelationsAkoya Biosciences, Inc.[email protected]
Media Contact:Christine Quern(617) 650-8497[email protected]
Source: Akoya Biosciences, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Foundation for Sarcoidosis Research Announces 13 Inaugural Sites for Groundbreaking FSR Clinical Data Registry
- RWB Completes Transformational Florida Divestiture, Expected to Eliminate Over $123 Million of Liabilities and Significantly Strengthen the Company’s Balance Sheet
- JPMorganChase Reports Second-Quarter 2026 Financial Results
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
Canaccord GenuitySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share